Humpa, Ian Carl T.
HRN: 12-68-45 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/24/2023
CEFUROXIME 1.5GM (VIAL)
08/24/2023
08/30/2023
IVTT
810mg
Q8h
Dengue With WS, T/C Partial Obstruction
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes